2025/07/10 by Tracy Murphy, Boyang Zhang, Tong Zhang +21 · 1 voice
Medicine · #Acute Myeloid Leukemia Research #Neutropenia and Cancer Infections
paper · pdf · doi:10.3324/haematol.2025.287777
openalex publication_date 2025/07/10 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/22
Acute myeloid leukemia (AML) patients exhibit diverse molecular and cytogenetic changes with heterogeneous outcomes. The functionally-derived LSC17 gene expression score has demonstrated strong prognostic significance in retrospective analyses of adult and pediatric AML cohorts, where above-median scores are associated with worse outcomes compared to below-median scores in intensively-treated patients. Here we used a laboratory-developed clinically-validated NanoString-based LSC17 assay to test the prognostic value of the LSC17 score in a prospective multicenter study of 276 newly-diagnosed AML patients. Each patient's score was classified as high or low by comparison to a previously-established reference score. In the entire cohort, a high LSC17 score was associated with poor risk features, including advanced age and unfavorable genetic mutations. In the subset of 190 patients treated intensively, a high LSC17 score was associated with lower remission rates (63% vs. 94% after induction; P<0.0001), presence of measurable residual disease (46% vs. 10%; P<0.0001), and shorter overall survival (OS, 606 days vs. not reached; P=0.0004; hazard ratio [HR] =2.16; 95% confidence interval [CI]: 1.39-3.35) and relapse-free survival (RFS, 541 days vs. not reached; P=0.001; HR=1.99; 95% CI: 1.29-3.08). In multivariable analysis considering age, white blood cell count and European LeukemiaNet 2022 risk groups, the LSC17 score remained an independent predictor of RFS and OS. Allogeneic stem cell transplantation improved OS for patients with a high but not a low LSC17 score. This study establishes the real-world value of the LSC17 score as a robust tool for risk assessment in AML and paves the way for its incorporation into routine clinical practice.